Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst David Hynes maintains a Hold rating on Definitive Healthcare (NASDAQ:DH) and lowers the price target from $10 to $8.
May 08, 2024 | 4:41 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Canaccord Genuity maintains a Hold rating on Definitive Healthcare and reduces the price target from $10 to $8.
The reduction in price target by Canaccord Genuity suggests a bearish outlook on the stock, potentially leading to a short-term negative impact on its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100